MDaudit Releases “AI Assist” to Empower Healthcare Revenue Integrity Teams with Rapid, Actionable Responses to Drive Financial Outcomes

April 2, 2025 9:00 AM

MDaudit, an award-winning cloud-based continuous risk monitoring platform for RCM that enables the nation's premier healthcare organizations to minimize billing risks and maximize revenues, today announced the latest AI-powered enhancement to its award-winning revenue integrity platform. AI Assist leverages artificial intelligence (AI), machine learning (ML), and natural language processing (NLP) to instantly transform an overwhelming volume of...

Read more

Vastian Announces Partnership with The Leapfrog Group

April 2, 2025 9:00 AM

Vastian, a leading provider of quality management software for hospitals and laboratories, today announced its partnership with The Leapfrog Group, an independent national watchdog organization of employers and other purchasers focused on health care safety.Based in Washington, DC, The Leapfrog Group was founded in 2000 with the goal of improving American health care quality and transparency by reporting information on medical errors, accidents...

Read more

Yunu Fosters Outstanding Innovation with NextGen Scientist Awards at Huntsman Cancer Institute Symposium

April 2, 2025 8:00 AM

Yunu, creator of the industry's first end-to-end clinical trial imaging workflow platform supporting sites, CROs and pharma, was proud to sponsor the 2025 HCI Frontiers Symposium's NextGen Scientist Awards. This premier event, hosted by the Huntsman Cancer Institute (HCI), occurred from February 17-19, 2025, in Salt Lake City, Utah. The symposium explored groundbreaking models in cancer care, screening, risk identification, diagnosis, treatment,...

Read more

Sunshine Biopharma Announces Positive Results of mRNA Therapy for Cancer

April 2, 2025 8:00 AM

Sunshine Biopharma Inc. (NASDAQ:SBFM) ("We", "Our", the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that it has completed additional studies on orthotopic human tumor models in mice confirming its K1.1 mRNA Lipid Nanoparticle (K1.1-mRNA-LNP) product as a novel therapeutic agent for human hepatocellular carcinoma.Human...

Read more

Patient Voices Highlight the Realities of Living with Irritable Bowel Syndrome During IBS Awareness Month

April 2, 2025 8:00 AM

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals ("Salix"), today announced the launch of IBS Symptoms Aren't Black and White: Living in the Gray, an authentic storytelling campaign that addresses the complexities of living with irritable bowel syndrome (IBS). Throughout April, which is IBS Awareness Month, Salix will be sharing patient stories on LinkedIn, highlighting the unique...

Read more

Jamie Zacharias, MD Has Been Selected for Inclusion in the Nationwide Registries Top Doctors of America 2025 Honors Edition

April 2, 2025 8:00 AM

Penn Medicine Becker ENT & Allergy proudly announces that Dr. Jamie Zacharias, a distinguished physician at the practice's Sewell, NJ and Voorhees, NJ locations, has been recognized by the Nationwide Registries Top Doctors of America. Her selection for the organization's 2025 Honors Edition highlights the expertise, dedication, and community-minded approach she brings to the field of medicine. This latest accolade underscores the significance of...

Read more

NHI Announces $63.5 Million Senior Housing Investment

April 2, 2025 6:00 AM

National Health Investors, Inc. (NYSE:NHI) announced today that it has invested $63.5 million, inclusive of transaction costs, for the acquisition of a portfolio of six memory care communities with 205 units in Nebraska operated by Agemark Senior Living. The communities are operated under the CountryHouse brand which Agemark established in 1997 exclusively for residents requiring personalized memory care. The communities are in a master lease...

Read more

Rehab.com Releases Latest Drug Use and Overdose Data in 2025 Rehab Report

April 2, 2025 6:00 AM

Rehab.com has released its latest iteration of its 2025 Rehab Report. As the drug crisis in the US continues to evolve, it's important that the media, addiction professionals, and the general public have access to regional drug trends in a digestible, easy-to-understand format. The report combines data from various national agencies to present the latest trends at the national and state levels.The April 2025 update showcases a 2% decrease in...

Read more

Bionic Bloom Welcomes Back Former Executive Director Ethan Owens to Leadership Team

April 2, 2025 5:00 AM

Bionic Bloom, the nation's first legal psilocybin therapy center and an award-winning leader in integrative mental health, is proud to announce the return of Ethan Owens as Executive Director. Owens previously held the position during a pivotal time of growth for the organization and rejoins the leadership team to help usher in a new era of expansion, innovation, and community impact."Ethan brings heart, vision, and a rare combination of...

Read more

New Scientific Article in Nature Linking the Potential use of NeuroRestore ACD856 for the Treament of Obesity

April 2, 2025 4:00 AM

AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) - AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, announced today that an article has been published in Nature suggesting the use of NeuroRestore ACD856 in the treatment of obesity.The article, entitled Missense variants in FRS3 affect body mass index in populations of...

Read more

Eldex Optos Series Pumps Gain Visibility With Bioz's Citation-Powered Badges

April 2, 2025 4:00 AM

Bioz, Inc., the industry standard for AI-driven citation tracking, is empowering researchers with real-time insights by integrating Bioz Badges into Eldex's product webpages. This seamless addition provides dynamically updating citations from peer-reviewed publications, helping scientists quickly evaluate the impact of Eldex's Optos Series Pumps in real-world research.By implementing Bioz Badges, Eldex has enhanced visibility into how its...

Read more

Ondine Biomedical Inc. Announces Mid Yorkshire NHS Trust cuts SSI rates by 71%

April 2, 2025 2:00 AM

Ondine Biomedical Inc. (LON:OBI) reports that results from the first NHS deployment of Steriwave® nasal decolonization technology at Mid Yorkshire Teaching NHS Trust (Mid Yorks) have demonstrated a substantial reduction in surgical site infections (SSI) following elective knee and hip replacement surgery. A new health economic analysis conducted by the world-renowned York Health Economics Consortium (YHEC) also found that Mid Yorks' use of...

Read more

ATMOS Inc. Announces FDA Clearance for its Cardiothoracic Digital Drain, Helping Patients To Go Home Sooner After Lung Resection Surgery

April 2, 2025 12:00 AM

Designed to support Enhanced Recovery After Surgery (ERAS)® protocols, the C 051 empowers surgeons and postoperative teams with objective data on air leaks, enabling faster clinical decision-making for earlier chest tube removal and ultimately reducing hospital length of stay.Early ambulation is a key factor in recovery, yet traditional drainage systems tether patients to wall suction or restrict patient movement. "The ATMOS C 051 with its small...

Read more

MedMira Reports Second Quarter Results FY2025

April 1, 2025 10:00 PM

MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended January 31, 2025.Corporate updateIn Q2 FY2025, MedMira has received the Health Canada approval of its Multiplo® Rapid TP/HIV Test (Multiplo® TP/HIV) and Reveal® Rapid HIV Test. In addition, the Company continued its regulatory work in Canada on two new products and is in the final stages for its clinical trials for the Reveal® G4 HIV-1/2 rapid test...

Read more

Singleton Schreiber Leads Efforts to Secure Justice for Women Affected by Depo-Provera

April 1, 2025 6:50 PM

Singleton Schreiber is dedicated to supporting women who developed meningioma, a type of brain tumor, after receiving the Depo-Provera birth control shot. The firm's lawsuit alleges that the manufacturers of Depo-Provera and its generic equivalents, including Pfizer, failed to properly warn women of the increased risk of developing a meningioma while using the drug.The firm, known for its commitment to pharmaceutical negligence cases, is...

Read more

Sunshine Biopharma Reports Revenue of $34.9M in Fiscal 2024, Up 45% From Last Year

April 1, 2025 5:09 PM

FORT LAUDERDALE, FL / ACCESS Newswire / April 1, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that it has filed its 2024 annual report on Form 10-K on Tuesday, April 1, 2025. The following are highlights of the report:Revenue in 2024 grew to $34.9 million, a 45% increase over...

Read more

Total Health Revive on Why Modern Medicine is Failing Chronic Illness Patients - And What Needs to Change

April 1, 2025 5:00 PM

For decades, the conventional healthcare system has been the go-to solution for individuals struggling with chronic illnesses. Yet, despite the trillions of dollars poured into modern medicine, millions of people remain trapped in a cycle of medication dependency, symptom management, and frustration. Why? Because the current healthcare model is fundamentally ill-equipped to address chronic conditions at their root cause. Dr. Brian Anderson, the...

Read more

Jaguar Health Announces Closing of Bridge Financing Priced At-The-Market Under Nasdaq Rules

April 1, 2025 4:15 PM

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or "the Company"), today announced the closing of its previously announced private placement.Jaguar's president and chief executive officer Lisa Conte, as well as other members of the Company's board of directors and other C-suite and senior executives of Jaguar along with selected institutional and accredited investors (each, an "Investor") entered into securities purchase agreements in connection...

Read more

Inspired Spine Welcomes Ross Matlack as CEO of the Inspired Spine Conglomerate for National and Global Expansion

April 1, 2025 4:00 PM

Inspired Spine is pleased to announce the appointment of Ross Matlack, FACHE as the new Chief Executive Officer of the Inspired Spine conglomerate. This strategic leadership transition marks a bold step forward in the organization's mission to expand both nationally and globally. Ross brings a wealth of experience as a high-level healthcare attorney and former CEO of multiple hospitals, with a proven track record of successfully leading...

Read more

Viromed Medical AG: UMECO Group Acquires Exclusive Marketing Rights in Asia for Cold Plasma Medical Devices ViroCAP(R) and PulmoPlas(R)  

April 1, 2025 3:30 PM

Viromed Medical AG ("Viromed", ticker:VMED; ISIN:DE000A3MQR65), a medical technology company and pioneer of cold plasma technology for applications in air disinfection, wound healing and intensive care medicine, has today signed an exclusive distribution agreement worth a total of EUR 152.5 million with UMECO Group ("Umeco") a leading Asian distributor of medical devices in cosmetics and medicine based in Korea, for the commercialization of the...

Read more